Clinical Trials List
2023-12-26 - 2026-05-14
Phase III
Not yet recruiting5
Recruiting1
ICD-10M33.00
Juvenile dermatopolymyositis, organ involvement unspecified
ICD-10M33.09
Juvenile dermatopolymyositis with other organ involvement
ICD-10M33.10
Other dermatopolymyositis, organ involvement unspecified
ICD-10M33.19
Other dermatopolymyositis with other organ involvement
ICD-10M33.90
Dermatopolymyositis, unspecified, organ involvement unspecified
ICD-10M33.99
Dermatopolymyositis, unspecified with other organ involvement
ICD-10M36.0
Dermato(poly)myositis in neoplastic disease
ICD-9710.3
Dermatomyositis
xxxxxx
-
Sponsor
xxxxxx
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 楊凱介 Division of Rheumatology
- 黃建中 Division of Rheumatology
- Po-Hao Huang Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 郭佑民 風濕免疫科
- 呂政勳 風濕免疫科
- 鄭喬峰 風濕免疫科
- CHIEH-YU SHEN 風濕免疫科
- KO-JEN LI 風濕免疫科
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 陳彥輔 Division of Rheumatology
- Shue-Fen Lo Division of Rheumatology
- 張哲慈 Division of Rheumatology
- Ping-Han Tsai Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 曹彥博 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 謝佳偉 Division of Rheumatology
- 譚國棟 Division of Rheumatology
- 顏在弘 Division of Rheumatology
- Yi-Hsing Chen Division of Rheumatology
- HSIN-HUA CHEN Division of Rheumatology
- 吳沂達 Division of Rheumatology
- WEN-NAN HUANG Division of Rheumatology
- Yi-Ming Chen Division of Rheumatology
- 陳彥如 Division of Rheumatology
- 謝祖怡 Division of Rheumatology
- 林靖才 Division of Rheumatology
- 廖育婉 Division of Rheumatology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Placebo for PF-06823859
Dosage Form
270
Dosage
NA
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
11 participants
-
Global
318 participants
